{"id":557674,"date":"2026-06-28T00:33:23","date_gmt":"2026-06-28T00:33:23","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/557674\/"},"modified":"2026-06-28T00:33:23","modified_gmt":"2026-06-28T00:33:23","slug":"oracle-orcl-expands-into-defense-and-healthcare-with-new-ai-partnerships","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/557674\/","title":{"rendered":"Oracle (ORCL) Expands Into Defense And Healthcare With New AI Partnerships"},"content":{"rendered":"\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/simplywall.st\/features\/portfolio?utm_medium=finance_user&amp;utm_campaign=portfolio_head_cta&amp;utm_source=yahoo&amp;blueprint=4639526\" data-ylk=\"slk:Track%20your%20investments%20for%20FREE;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Track your investments for FREE&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Track your investments for FREE<\/a> with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.  <\/p>\n<ul class=\"yf-1jsc1up\">\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Oracle (NYSE:ORCL) has launched the third cohort of its Defense Ecosystem, adding new AI, cyber, and edge technology firms to support national security and allied defense programs.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The company is expanding AI powered healthcare partnerships, including work with Baystate Health and Theator, to apply its technology to clinical operations, patient engagement, and documentation automation.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">These moves come alongside a rise in AI related infrastructure deals that put Oracle&#8217;s cloud and AI tools to work in regulated, mission critical settings.  <\/p>\n<\/li>\n<\/ul>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">For investors tracking Oracle, this set of announcements extends the story beyond cloud infrastructure headlines and restructuring news. The Defense Ecosystem&#8217;s third cohort brings a larger group of mission focused partners into Oracle&#8217;s orbit, tying its AI and cloud platforms more directly to defense, cybersecurity, and edge computing projects where reliability and compliance are central.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">On the healthcare side, Oracle Health&#8217;s partnerships with providers such as Baystate Health and surgical intelligence firm Theator point to growing usage of Oracle&#8217;s AI in real world clinical workflows. Together with the surge in AI linked infrastructure agreements, these developments may shape how the company positions itself across regulated sectors over the coming years.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Stay updated on the most important news stories for <a href=\"https:\/\/www.simplywall.st\/\/company\/id\/ae500fca-e97b-4d2c-9527-8a1d14d803f2\/valuation?utm_medium=finance_user&amp;utm_campaign=news_stay_updated_cta&amp;utm_source=yahoo\" data-ylk=\"slk:Oracle;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Oracle&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Oracle<\/a> by adding it to your <a href=\"https:\/\/simplywall.st\/features\/stock-watchlist?utm_medium=finance_user&amp;utm_campaign=news_stay_updated_cta&amp;utm_source=yahoo&amp;blueprint=4639526\" data-ylk=\"slk:watchlist;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;watchlist&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">watchlist<\/a> or <a href=\"https:\/\/simplywall.st\/features\/portfolio?utm_medium=finance_user&amp;utm_campaign=news_stay_updated_cta&amp;utm_source=yahoo&amp;blueprint=4639526\" data-ylk=\"slk:portfolio;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;portfolio&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">portfolio<\/a>. Alternatively, explore our <a href=\"https:\/\/simplywall.st\/stock\/NYSE\/ORCL?utm_medium=finance_user&amp;utm_campaign=news_stay_updated_cta&amp;utm_source=yahoo&amp;blueprint=4639526\" data-ylk=\"slk:Community;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Community&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Community<\/a> to discover new perspectives on Oracle.  <\/p>\n<p>    <a href=\"https:\/\/www.simplywall.st\/company\/id\/ae500fca-e97b-4d2c-9527-8a1d14d803f2?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"NYSE:ORCL Earnings &amp; Revenue Growth as at Jun 2026\" height=\"613\" width=\"960\" class=\"yf-lglytj loader\"\/><\/a> NYSE:ORCL Earnings &amp; Revenue Growth as at Jun 2026           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/www.simplywall.st\/company\/id\/ae500fca-e97b-4d2c-9527-8a1d14d803f2?utm_medium=finance_user&amp;utm_campaign=cta_news_full_picture&amp;utm_source=yahoo\" data-ylk=\"slk:%F0%9F%93%B0%20Beyond%20the%20headline%3A%202%20risks%20and%204%20things%20going%20right%20for%20Oracle%20that%20every%20investor%20should%20see.;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;\ud83d\udcf0 Beyond the headline: 2 risks and 4 things going right for Oracle that every investor should see.&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">\ud83d\udcf0 Beyond the headline: 2 risks and 4 things going right for Oracle that every investor should see.<\/a>  <\/p>\n<p>        Quick Assessment      <\/p>\n<ul class=\"yf-1jsc1up\">\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><strong>\u2705 Price vs Analyst Target<\/strong>: At US$148.53 versus a US$252.64 analyst target, Oracle trades about 41% below consensus.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><strong>\u2705 Simply Wall St Valuation<\/strong>: The stock is flagged as undervalued, trading 63.4% below an internal fair value estimate.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><strong>\u274c Recent Momentum<\/strong>: The share price is down 22.2% over the past 30 days, so recent momentum has been weak.  <\/p>\n<\/li>\n<\/ul>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">There&#8217;s only one way to know the right time to buy, sell or hold Oracle. Head to Simply Wall St&#8217;s <a href=\"https:\/\/www.simplywall.st\/company\/id\/ae500fca-e97b-4d2c-9527-8a1d14d803f2\/valuation?utm_medium=finance_user&amp;utm_campaign=cta_news_fair_value&amp;utm_source=yahoo\" data-ylk=\"slk:company%20report%20for%20the%20latest%20analysis%20of%20Oracle&#039;s%20Fair%20Value;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;company report for the latest analysis of Oracle&#039;s Fair Value&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">company report for the latest analysis of Oracle&#8217;s Fair Value<\/a>.  <\/p>\n<p>        Key Considerations       <\/p>\n<ul class=\"yf-1jsc1up\">\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">\ud83d\udcca The Defense Ecosystem expansion and AI healthcare deals tie Oracle more tightly to regulated, mission critical workloads where switching costs can be high.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">\ud83d\udcca Watch how AI related infrastructure revenue, large regulated sector contracts, and Oracle Cloud usage trends are reported in upcoming results.  <\/p>\n<\/li>\n<li class=\"yf-1jsc1up\">\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">\u26a0\ufe0f High debt and a flagged level of non cash earnings mean you may want to check cash generation and balance sheet flexibility alongside this AI push.  <\/p>\n<\/li>\n<\/ul>\n<p>         Dig Deeper         <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">For the full picture including more risks and rewards, check out the <a href=\"https:\/\/www.simplywall.st\/company\/id\/ae500fca-e97b-4d2c-9527-8a1d14d803f2?utm_medium=finance_user&amp;utm_campaign=cta_news_deeper_analysis&amp;utm_source=yahoo\" data-ylk=\"slk:complete%20Oracle%20analysis;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;complete Oracle analysis&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">complete Oracle analysis<\/a>. Alternatively, you can check out the <a href=\"https:\/\/simplywall.st\/community\/narratives?utm_medium=finance_user&amp;utm_campaign=cta_news_deeper_analysis&amp;utm_source=yahoo&amp;blueprint=4639526\" data-ylk=\"slk:community%20page%20for%20Oracle;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;community page for Oracle&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">community page for Oracle<\/a> to see how other investors believe this latest news will impact the company&#8217;s narrative.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.<\/strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Companies discussed in this article include <a href=\"https:\/\/finance.yahoo.com\/quote\/ORCL\" data-ylk=\"slk:ORCL;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;ORCL&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"nofollow noopener\">ORCL<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><strong>Have feedback on this article? Concerned about the content? <\/strong><a href=\"https:\/\/investor-research.typeform.com\/to\/wvg6MFri#feedback_token=NDYzOTUyNjpkNmNlMWM5NWM1ZGMzYWQ2&amp;company=NYSE:ORCL&amp;blueprintid=4639526\" data-ylk=\"slk:Get%20in%20touch;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Get in touch&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>Get in touch<\/strong><\/a><strong> with us directly.<\/strong> Alternatively, email <a href=\"https:\/\/finance.yahoo.com\/technology\/ai\/articles\/mailto:editorial-team@simplywallst.com?subject=Re%3A%20Your%20article%20on%20NYSE%3AORCL%20(yahoo)%20from%2027th%20June%202026\" data-ylk=\"slk:editorial-team%40simplywallst.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;editorial-team@simplywallst.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">editorial-team@simplywallst.com<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million&hellip;\n","protected":false},"author":2,"featured_media":557675,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[275],"tags":[238521,39221,18,135,475,474,19,17,37217,63358,19378],"class_list":["post-557674","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-baystate-health","tag-cloud-infrastructure","tag-eire","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-ireland","tag-mission-critical","tag-oracle-cloud","tag-patient-engagement"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116824926187001289","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/557674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=557674"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/557674\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/557675"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=557674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=557674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=557674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}